- Home
- PFE
PFE
Pfizer Inc.
as 11-20-2024 4:00pm EST
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
| Founded: | 1849 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 166.8B | IPO Year: | N/A |
| Target Price: | $33.17 | AVG Volume (30 days): | 53.5M |
| Analyst Decision: | Buy | Number of Analysts: | 13 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 0.74 | EPS Growth: | -59.45 |
| 52 Week Low/High: | $24.48 - $31.54 | Next Earning Date: | 10-29-2024 |
| Revenue: | $59,375,000,000 | Revenue Growth: | -14.29% |
| Revenue Growth (this year): | 8.76% | Revenue Growth (next year): | 0.37% |
Stock Insider Trading Activity of Pfizer Inc. (PFE)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Gottlieb Scott | PFE | Director | Oct 30 '24 | Buy | $28.24 | 1,000 | $28,240.00 | 10,000 |
Latest Pfizer Inc. News
PFE Breaking Stock News: Dive into PFE Ticker-Specific Updates for Smart Investing
Zacks
15 hours ago
5 Year-to-Date Laggards to Buy Amid Solid Near-Term Upside Potential
MT Newswires
16 hours ago
Pfizer, Flynn Get Fined $87.3 Million by UK Tribunal for Excessive Pricing on Epilepsy Drug
GuruFocus.com
18 hours ago
Pfizer Appoints Cancer Research Head Chris Boshoff as New R&D Chief
Zacks
20 hours ago
Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan
MT Newswires
a day ago
Pfizer Names Chris Boshoff as Chief Scientific Officer, R&D Head
Business Wire
a day ago
Pfizer Announces New Chief Scientific Officer and President, Research & Development
Reuters
a day ago
Pfizer names oncology head Chris Boshoff as R&D chief
The Wall Street Journal
a day ago
Pfizer Names New R&D Chief
Compare PFE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PFE Pfizer Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.